Compare EPAM Systems Inc (EPAM) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EPAM Systems Inc vs Regeneron Pharmaceuticals Inc — how do they compare? EPAM Systems Inc trades at $88.1 (market cap $4.49B), while Regeneron Pharmaceuticals Inc trades at $677.41 (market cap $69.66B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 15.5× EPAM Systems Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.57% dividend while EPAM Systems Inc pays none. Which is the better fit depends on your goals.
| EPAM | REGN | |
|---|---|---|
Market Cap | $4.49B | $69.66B |
Sector | Technology | Health |
52-Week High | $221.40 | $812.27 |
52-Week Low | $76.04 | $542.52 |
Enterprise Value | $3.74B | $63.61B |
Dividend Yield | — | 0.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EPAM Systems trades at $88.59, up 4.84% today, with a bearish technical signal but strong fundamentals including a P/E of 12.35 and P/S of 0.86. Recent earnings beats and a consensus analyst price target of $128.55 suggest undervaluation, while cash flow trends show operational strength despite a net decline in 2026 projections. The stock faces headwinds from AI sector volatility but benefits from strategic partnerships and AI-native revenue growth.
The outlook for EPAM is cautiously optimistic, with significant upside potential based on analyst targets, though risks include competitive pressures and macroeconomic uncertainty. Investment opportunity lies in its valuation discount and digital engineering expertise, but investors should monitor execution on AI initiatives and sector sentiment shifts for near-term direction.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EPAM Systems Inc
EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.
Read more on EPAM →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
